Ion activated bioadhesive in situ gel of clindamycin for vaginal application by Gupta, Himanshu & Sharma, Aarti
International Journal of Drug Delivery 1(2009) 32-40 
http://www.arjournals.org/ijodd.html 
 
Research article 
                                                            
ISSN: 0975-0215 
Ion activated bioadhesive in situ gel of clindamycin for vaginal application 
Himanshu Gupta1*, Aarti Sharma2 
 
*Corresponding author: 
Himanshu Gupta 
 
1Department of Pharmaceutics, 
Faculty of Pharmacy,  
Jamia Hamdard 
(Hamdard University),  
New Delhi,  
India 
Email: 
himanshu18in@yahoo.com 
 
2School of Pharmacy,  
Jaipur National University, 
Jaipur, India 
 
 
 
 
 
Abstract 
Vaginal preparations, although generally perceived as safer most , still they 
are associated with a number of problems, including multiple days of dosing, 
dripping, leakage and messiness, causing discomfort to users and expulsion 
due to the self-cleansing action of the vaginal tract. These limitations lead to 
poor patient compliance and failure of the desired therapeutic effects. For 
effective vaginal delivery of antimicrobial agents, the drug delivery system 
should reside at the site of infection for a prolonged period of time. In our 
present work, we have developed and optimized a chitosan (bioadhesive and 
permeation enhancer) and gellan gum (ion activated gelling polymer) based 
in situ gel system of clindamycin for vaginal application. The developed 
formulation was characterized for various in-vitro parameters e.g. clarity, 
refractive index, pH, isotonicity, sterility, viscosity, drug release profile, 
statistical release kinetics, bioadhesive force, retention time, microbial 
efficacy, irritation test and stability studies. To simulate vaginal conditions, a 
synthetic membrane (cellophane hydrated with modified simulated vaginal 
fluid) and sheep vaginal mucosa were used as model membranes. The 
developed formulation was found to be non irritant, bioadhesive with good 
retention properties. Developed formulation shows matrix model release 
kinetic by PCP disso software. The developed formulation is thus a viable 
alternative to conventional vaginal dosage forms. 
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Introduction  
 
The vagina, unlike other systems is highly dynamic 
with respect to absorption of drugs, their 
metabolism and their elimination. The vaginal 
defense i.e. epithelium, flora, immune cells and pH 
make it favorable site for local and systemic 
delivery of drugs that are used specifically for the 
treatment of female-related conditions. The vaginal 
cavity has traditionally been used for local delivery 
of drugs such as prostaglandins, steroids, 
antibiotics, antifungal, antiprotozoal, 
antichlamydial,  antiviral,   and   spermicidal  agents  
 
 
 
[1]. Recently, there has been increased interest in 
vaginally administered agents and formulations 
known as ‘‘microbicides,’’ which provide effective 
contraception and protection against transmission of 
various sexually transmitted infections (STDs), 
including acquired immunodeficiency syndrome 
(AIDS) [2]. In addition, vaginal preparations 
include products meant for the maintenance of 
reproductive hygiene, enhancement of sexual 
pleasure, and moisturizing the vaginal mucosa in 
case of dry vagina in postmenopausal women. 
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Several kinds of vaginal dosage forms have been 
developed, such as sponges, rings, suppositories, 
tablets, tampons, foams, films, gels, and creams. 
Vaginal preparations, although generally perceived 
as safer most but still these are associated with a 
number of problems, including multiple days of 
dosing, dripping, leakage and messiness, causing 
discomfort to users and expulsion due to the self-
cleansing action of the vaginal tract. These 
limitations lead to poor patient compliance and 
failure of the desired therapeutic effects.  For 
effective vaginal delivery of antimicrobial agents, 
the drug delivery system should reside at the site of 
infection for a prolonged period of time [3].  
The conventional dosage forms i.e 
preformed gel and solution have a number of 
lacunas, which has limited their use in vaginal drug 
delivery. Direct application of gels onto the infected 
sites of the vagina might be difficult, inconvenient 
as well as have frequent dosing because the 
conventional gels do not remain for long time at the 
site of application. A new and recent approach is to 
try to combine advantages of both gels and solution 
so that an accurate dose can be administered with 
ease of administration i.e in-situ gel system. These 
formulations remain to a solution state before 
administration but however transforms to gel after 
administration in to vaginal cavity. Some researcher 
explored efficacy of in situ vaginal gel. The liquid 
applied to topical areas turns into gels as a result of 
physical and/or chemical change induced by 
physiological environments such as pH for cellulose 
acetate phthalate, the concentration of calcium ions 
for gellan gum, temperature for poloxamers, etc. 
[4]. 
Bioadhesion and retention at the site of 
application for a sufficient period of time can be 
achieved by incorporating bioadhesive polymers in 
the formulations. Till date, only a limited number of 
studies have been reported on bioadhesive drug 
delivery systems for vaginal administration. 
Chitosan is a natural polymer obtained by 
deacetylation of chitin. Chitosan act both as 
bioadhesive and permeation enhancer. It also 
possesses antimicrobial and wound-healing 
properties [5]. Gellan gum is an ion activated 
polymer, which gel when comes in contact with 
ions i.e vaginal fluid. 
Clindamycin phosphate is a water soluble semi-
synthetic antibiotic. Clindamycin inhibits bacterial 
protein synthesis at the level of the bacterial 
ribosome. The antibiotic binds preferentially to the 
50S ribosomal subunit and affects the process of 
peptide chain initiation. Clindamycin is indicated 
for the treatment of bacterial vaginosis (formerly 
referred to as Haemophilus vaginitis, Gardnerella 
vaginitis, non-specific vaginitis, Corynebacterium 
vaginitis, or anaerobic vaginosis) in non-pregnant 
women. We are using clindamycin as a model drug 
for our present study to check the efficacy of the 
developed formulation. 
  Hence, in our present work, we are developing 
and optimizing a bioadhesive chitosan and gellan 
gum based in situ gel system of clindamycin for 
vaginal application. The optimized gel was 
evaluated for various physicochemical properties, in 
vitro drug release, bioadhesive force, retention time, 
microbial efficacy, irritation test, and stability 
studies. 
 
Materials and Method 
 
Clindamycin phosphate was obtained as gift 
samples from Glenmark Pharmaceuticals, Mumbai, 
India. Chitosan (practical grade, 75-85% 
deacetylated, molecular weight 150 kDa) was 
obtained as kind gift from M/s, India Sea Foods, 
Cochin, India. Gellan gum (Gelrite ® CP Kelco, 
US) was obtained as a gift from Applied 
Biosciences, Mumbai, India. All other chemicals 
and solvents used were purchased from local 
suppliers and of analytical grade unless mentioned.  
 
Preparation of simulated vaginal fluid (SVF) 
 
The simulated vaginal fluid was prepared from 3.51 
gL-1 NaCl, 1.40 gL-1 KOH, 0.222 gL-1 Ca(OH)2, 
0.018 gL-1 bovine serum albumin, 2 gL-1 lactic acid, 
1 gL-1 acetic acid, 0.16 gL-1 glycerol, 0.4 gL-1 urea 
and, 5 gL-1 glucose. pH of the mixture was adjusted 
to 4.5 ±0.02 using 0.1 M HCl [6]. 
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Interaction studies 
 
Liquid solutions of chitosan, gellan gum and 
clindamycin phosphate was prepared individually 
and in combinations and were autoclaved at 121°C 
for 20 min at 15 psi. The ultraviolet spectra were 
taken before and after autoclaving using double 
beam ultraviolet-visible spectrophotometer. Both 
spectra were compared for any possible change due 
to interactions between different ingredients. 
 
Preparation of placebo Gel System 
 
Different concentrations of chitosan and gellan gum 
were prepared and evaluated for their gelling 
capacity in order to identify the compositions 
suitable for use as in in situ gelling systems (Table 
1). Chitosan, a pH sensitive polysaccharide was 
dissolved in 1% v/v acetic acid diluted further with 
phosphate buffer system, pH adjusted to 5.0. Gellan 
gum, an ion activated polymer was dissolved in 
phosphate buffered saline, pH 5.0. The gelling 
capacity was determined by placing a drop of the 
system in a vial containing 2 ml of freshly prepared 
simulated vaginal fluid and visually assessing the 
gel formation, noting the time taken for gelation and 
time taken by gel formed to dissolve. 
 
 
Medicated in- situ gel formulation 
 
For antibacterial activity clindamycin phosphate 
was available as 2% of vaginal cream. Hence a dose 
of 2% was used in present formulation. The 
weighed quantity of drug was placed in volumetric 
flask and dissolved in normal saline under aseptic 
conditions. 0.1% of methyl paraben was added as a 
preservative. The resultant polymeric solutions were 
mixed well and kept undisturbed at room 
temperature for 24 hours to ensure proper mixing. 
Osmolarity of the formulation was determined by 
osmometer (Fiske Associate, USA) and required 
amount of sodium chloride was added and mixed 
thoroughly to make solution isotonic. Complete 
formula of the developed formulation was given in 
Table 2. The solution was transferred into amber-
colored bottles and sealed till further use. The 
resulting solutions were sterilized by autoclaving at 
121°C for 20 min at 15 psi 
Physicochemical Characterization  
Formulations were tested for different 
physicochemical properties as described and results 
are shown in Table 3 
Clarity and Refractive Index 
The clarity of the formulations after and before 
gelling was determined by visual examination of the 
formulations under light alternatively against white 
and black backgrounds. Refractive index of the 
formulations were determined by Abbe`s 
refractometer. 
pH Evaluation 
The pH of the formulation was recorded with a 
glass microelectrode (Mettler Instruments, 
Germany), and allowing it to equilibrate for 1 min. 
Experiments were performed in triplicate.  
 
Rheological measurements 
 
Rheological measurements were performed by a 
Brookfield Model DVIII+ Digital Rheometer 
(Brookfield Engineering Laboratories Inc., MA, 
USA). Brookfield Rheometer was used in which the 
test material is placed between two surfaces, one 
surface is rotated, and the torque resisting flow is 
measured. Simulated vaginal fluid (SVF) of pH 4.5 
was added in increments of 25 ml to 200 ml of the 
formulations, and the viscosity at which gelation 
occurred were recorded. This allows the 
determination of relationship between applied shear 
rate and shear stress experienced by the test material 
[7, 8]. All the measurements were conducted using 
SC4-14 spindle using about 4 ml sample volume at 
20rpm. The tests were performed in triplicate, with 
a coefficient of variation of less than 5% being 
found. Since, in vivo, vaginal formulations will 
experience the dilution with vaginal fluids and it has 
been reported that the rheological behavior of gels 
could be affected by various factors such as 
copolymer compositions and solutes [9]. 
 
In-vitro release kinetics 
The in vitro drug release was, performed in sink 
conditions, by means of a Franz diffusion cell, 
(PermeGear, Inc. Bethlehem, PA.) diameter 20 mm, 
with a water jacketed receptor chamber (15 ml) and 
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a donor chamber thermostated at 37°C. The 
receptor solution was constantly stirred at 600 rpm. 
The two chambers were separated by a cellulose 
membrane (Filter paper Whatman 41, 20-25μm, 
Whatman GmbH, Dassel, Germany) and each 
formulation (100 mg) was spread on a circular 
portion of the membrane. Drug release was 
determined by previously reported method of 
HPLC. [10] Briefly, The method uses a Hypersil 
ODS, 5 μm, 250×4.6 mm i.d. column maintained at 
45°C. The mobile phase comprises acetonitrile–
phosphate buffer (1.35% v/v phosphoric acid, 
adjusted to pH 6.0 with ammonium hydroxide)–
water (35:40:25, v/v) at a flow rate of 1.0 ml/min. 
Drug was quantified according to previously 
determined calibration curve (r= 0.9998), and 
reported as an average of 3 determinations. % 
cumulative drug released was plotted against each 
time point.  
 
 
Statistical Analysis 
 
The results of in vitro data were analyzed by 
statistical software PCP Disso, version 3.0, to obtain 
the best fit kinetic model for in vitro drug release 
from optimized formulation. 
 
 
Bioadhesion Measurement 
 
The assemblies developed for in vitro measurement 
of bioadhesive strength in a simulated vaginal 
environment are a modification of the previously 
reported bioadhesion test assembly [11]. The 
method is based on the measurement of tensile 
strength or shear stress required to break the 
adhesive bond between a model membrane and the 
test formulation. The test formulation is sandwiched 
between two model membranes fixed on flexible 
supports in the assemblies for a sufficient period of 
time. After the adhesive bond has formed, the force 
(weight) required to separate the bond was 
measured and calculated as bioadhesive strength. 
 
 
Ex- Vivo Retention Measurement 
 
Another desirable property of vaginal formulations 
is retention in the vaginal cavity for a desired period 
of time. An intact tubular piece of sheep vagina (cut 
to 3 in long; thawed in normal saline containing 
0.1% w/v sodium azide) was procured from a 
slaughter house. Vagina was suspended vertically 
with the help of a loop of wire and a stand [12]. The 
tissue was surrounded with a cotton pad moistened 
with normal saline, further surrounded by aluminum 
foil in order to keep the tissue moist for the duration 
of the experiment. An electronic balance was placed 
below the suspended tissue to measure the weight of 
gel falling down. The room temperature was 
maintained at 37±2ºC. A test sample (4mL) was 
introduced into the isolated vaginal tube with the 
help of a 10mL syringe (without needle), taking 
care to avoid spillage. The expulsion of gel from the 
lower end under the influence of gravity was then 
recorded as a function of time for 2 hr as a measure 
of retention.  
 
 
Microbiological Studies 
 
The microbiological studies were carried out on the 
optimized formulation and 2% w/v of plain drug 
solution for comprison against micro-organism. 
Staphylococcus aureus was used as the test micro-
organism. A layer of nutrient agar (20 mL) seeded 
with the test micro-organism (0.2 mL) was allowed 
to solidify in the petriplate. Cups were made on the 
solidified agar layer with the help of sterile borer at 
4 mm diameter. Then volume of the formulations 
(optimized formulation and plain drug solution) 
containing equivalent amount of drug was poured 
into the cups. After keeping petriplates at room 
temperature for 4 hr, the plates were incubated at 
37◦C for 24 hr. The zone of inhibition was obtained. 
The diameter of zone of inhibition was measured by 
an antibiotic zone finder [13]. 
Irritation Test (HET-CAM Test) 
For the present study, modified HET-CAM test as 
reported by (Velpandian et al, 2006) was carried 
out. [14] The HET-CAM has been shown to be a 
qualitative method of assessing the potential 
irritancy of chemicals. The potential irritancy of 
compounds may be detected by observing adverse 
changes that occur in the chorionallantoic 
membrane  of the egg after exposure to test 
chemicals.[15] Briefly, fertilized hen`s eggs were 
obtained from poultry farm. Three eggs for each 
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formulation weighing between 50-60 g were 
selected and candled in order to discard the 
defective ones. These eggs were incubated in 
humidified incubator at a temperature of 37 ± 0.5°C 
for 3 days. The trays containing eggs were rotated 
manually in a gentle manner after every 12 hours. 
On the day three, egg albumin (3 ml) was removed 
by using sterile techniques from the pointed end of 
the egg. The hole was sealed by 70% alcohol 
sterilized parafilm (American Can Company, USA) 
with the help of heated spatula. The eggs were kept 
in the equatorial position for the development of 
Chorioallantoic membrane (CAM) away from the 
shell. The eggs were candled on the fifth day of 
incubation and everyday, thereafter non-viable 
embryos were removed. On the tenth day a window 
(2X2 cm) was made on the equator of the eggs 
through which formulations (0.5 ml) were instilled 
directly onto the Cam surface and left in contact for 
5 minutes. The membrane is examined for vascular 
damage and the time taken for injury to occur is 
recorded. 
 A 0.9% NaCl solution was used as a control as it 
is reported to be practically non-irritant. The scores 
were recorded according to the scoring schemes as 
shown in Table 4 and score obtained was given in 
Table 5. 
Stability Studies 
Stability studies were carried out on optimized 
formulation according to ICH Guidelines. 3 packs 
of formulations were subjected to these stability 
studies. The packs were kept in Humidity and 
Temperature control cabinets (Topsun made) and 
maintained at 40οC, 75% relative humidity. The 
samples were withdrawn at 0, 60, 120 and 180 days 
and analysed by HPLC. The degradation rate 
constant (K) was deduced with equation slope= 
K/2.303. 
 
 
Results and Discussion 
 
Interaction studies were carried out to check any 
interaction between formulation ingredients. UV 
spectra obtained before and after autoclaving were 
found to be identical. No additional peak or shift in  
 
Table 1: Combinations of chitosan/gellan gum 
studied 
 
+ Very weak gel, transparent, dissolves rapidly; ++ gel forms, 
transparent, dissolves after sometimes; +++ firm gel, transparent, do 
not dissolve on standing; ++++ Instant gel, turbid, do not dissolve 
 
peak reveals two facts. First, the ingredients were 
compatible to each other and no physicochemical 
reactions took place, and secondly it also shows that 
the formulation can be terminally sterilized by 
autoclaving.  
The placebo formulations were developed using 
different combination of chitosan and gellan gum 
which were evaluated for their physicochemical 
characteristics like physical appearance and 
viscosity It’s prerequisite for an in situ gel system 
that it allows easy instillation into the cavity as 
liquid drops which undergoes sol-to-gel transition, 
triggered by presence of divalent cation ions of 
vaginal fluid. A concentration of 1% of both 
chitosan and gellan gum was selected as it gives a 
colorless and transparent formulation (Table 1) with 
good gelling capacity and taken further for 
evaluation. 2% of clindamycin phosphate is 
prescribed for antibacterial therapy for vaginal 
infections, hence we also used the same 
concentration to prepare medicated in situ gel 
formulation. 0.1% Methyl paraben was added as 
preservative and NaCl was added in calculated 
amount to maintain isotonicity of the formulation. 
Final formula was given in Table 2.  
 
 
 
Formulation Chitosan 
(% w/v) 
Gellan Gum
(% w/v) 
Gelling 
Capacity 
1 0.5 0.5 + 
2 1.0 0.5 ++ 
3 1.5 0.5 +++ 
4 0.5 1.0 ++ 
5 1.0 1.0 +++ 
6 1.5 1.0 ++++ 
7 0.5 1.5 +++ 
8 1.0 1.5 ++++ 
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   Table 2: Formula of the developed in situ formulation 
 
Ingredients Concentration 
(w/v) 
Clindamycin phosphate 2% 
Chitosan 1.0 % 
Gellan Gum 1.0 % 
NaCl 0.40% 
Methyl Paraben 0.1% 
Water (q.s.) 100% 
 
Physicochemical characterization of formulation 
The developed formulation was further 
characterized for various physiological parameters, 
like clarity, refractive index, viscosity, pH and 
osmolarity. The optimized chitosan/gellan gum 
vaginal gel is transparent in color. Refractive index 
of the gel is ranging from 1.335-1.337, proofing the 
transparency of gel. To avoid initial irritation due to 
difference in osmolarity of formulation and body 
fluid, the formulation was made iso-osmotic by 
addition of NaCl. The pH of the optimized 
formulations was found in the range of 5.0-5.5. 
(Table 3). Gellan gum converted into stiff gel in the 
presence of ions and results in sudden increase in 
the viscosity. The results were shown in Table 3. 
 
Table 3: Physicochemical properties of the developed in 
situ gel formulation 
 
Parameter Inference 
Clarity Clear solution 
pH 5.0-5.5 
Osmolarity 299-302 mOsmol 
Refractive Index 1.335-1.337 
Viscosity (at formulation condition) 87±2 cps 
Viscosity (in SVF) 438±5 cps 
Mucoadhesive force 0.118 N 
Retention time 98 minutes 
Values are expressed as mean ± S.D. (n=5) 
Rheological measurements 
 
The evaluation of rheological properties for the gel 
type dosage forms is important for predicting their 
behavior in vivo. All prepared gels and 
Clindamycin phosphate was submitted to 
rheological tests in order to study their flow 
properties. It is important to analyze such data 
because these characteristics can influence the 
formulation stability during the storage and in case 
of temperature changes. The prepared formulations 
showed a pseudoplastic flow, guarantying an 
immediate flow after stress application. This 
behaviour is desirable because it can promote good 
storage at room temperature and easy application. 
 
In vitro release kinetics 
 
In vitro drug release kinetics was carried out by the 
use of Franz diffusion cells in order to evaluate 
clindamycin in situ gel release profile. Initially the 
formulation demonstrates rapid release (burst 
effect) followed by slow and constant release for the 
rest of time. Fig. 1.  
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Fig 1: In vitro drug release profile of developed 
formulation. Values are expressed as mean±S.D. (n=5) 
 
This pattern confirms the controlled release 
behavior of the formulation. The initial burst effect 
is beneficial for antibiotics as it help achieving the 
therapeutic concentration of drug in minimal time 
followed by constant release to maintain sustained 
and control release of the drug. Developed 
formulation displayed 32.3% cumulative drug 
release after 2 h. 77.4% after 6 h and 97.2% after 12 
h. Burst effect might be due to initial migration of 
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the drug towards the surface of the matrix. Curve 
fitting of in vitro release data of optimized  
 
 
 
 
 
 
 
 
 
 
 
 
 
     Fig. 2: Graph showing release kinetics of optimized    
formulation 
 
formulation was compared with different release 
model to select best fitting model using PCP Disso 
V 3.0 software, confirming matrix release 
mechanism of drug release from in situ gel. The 
best fit kinetic model was matrix model (R = 
0.9615, k = 11.5296, t-test = 12.608 (passes) 
(Fig.2).  
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Fig 3: Area of zone of inhibition for the plain clindamycin  
   phosphate drug solution and optimized formulation 
 
 
Evaluation of mucoadhesive strength and 
retention time 
Bioadhesion and long retention are desirable 
characteristics of a vaginal formulation. Chitosan 
act as mucoadhesive as well as permeation 
enhancer. Performed adhesion force studies and 
retention studies proves the mucoadhesive nature of 
chitosan. The optimized formulation shows a 
bioadhesion force and retention time of 0.118 N and 
98 minutes respectively. Table 3, it was possible to 
note that chitosan possess good bioadhesive and 
retention properties. Chitosan presence improved 
gel performances and made them able to be 
employed in vaginal therapy. 
 
Table 4: Scoring chart for HET-CAM Test 
 
Effect Scores Inference 
No visible hemorrhage  
Just visible membrane discoloration 
Structures are covered partially due to membrane 
discoloration or hemorrhage 
Structures are covered totally due to membrane 
discoloration or hemorrhages 
0 
1 
2 
 
3 
Non-irritant 
Mild irritant 
Moderately 
irritant 
 
Severe 
irritant 
 
Microbiological Studies 
The optimized in situ gelling formulation showed 
antimicrobial activity when tested microbiologically 
by cup plate technique. Clear zone of inhibition 
were obtained. The diameter of zone of inhibition is 
shown in Figure 3. 
 
Irritation Test (HET-CAM Test) 
 
Irritation of the developed formulation was checked 
by Hen’s egg chorioallantoic membrane test which 
is a rapid, sensitive and inexpensive test. Testing 
with incubated eggs is a borderline case between in 
vivo and in vitro systems and does not conflict with 
the ethical and legal obligations. The 
Chorioallantoic membrane of the chick embryo is a 
complete tissue including viens, artries and 
capillaries and is technically very easy to study. It 
responds to injury with a complete inflammatory 
process [15]. Developed formulation was tested by 
using this method and result was compared with 
those obtained using normal saline, which was used 
as control that is supposed to be practically non-
irritant. A means score of 0 was obtained for normal 
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saline. Chitosan/gellan gum based formulation was 
non-irritant up to 2 h (mean score 0) while the mean 
score was found to be 0.33 up to 24 h (Table 5). The 
study shows that the formulation is non-irritant to 
mild irritant and is well tolerated. 
 
Table 5: Scores obtained in HET-CAM Test 
Scores 
Time (in minutes) 
Formulations 
0 5 15 30 60 120 240 480 1440 
Egg1 0 0 0 0 0 0 0 0 0 
Egg2 0 0 0 0 0 0 0 0 0 
Egg3 0 0 0 0 0 0 0 0 0 
N
or
m
al
 S
al
in
e 
as
 c
on
tr
ol
 
Mean 0 0 0 0 0 0 0 0 0 
Egg1 0 0 0 0 0 0 0 0 0 
Egg2 0 0 0 0 0 0 0 0 1 
Egg3 0 0 0 0 0 0 1 1 1 
D
ev
el
op
ed
 F
or
m
ul
at
io
n 
Mean 0 0 0 0 0 0 0.33 0.33 0.66 
 
 
Stability studies 
 
Stability study was carried out on the optimized 
formulation as per ICH guidelines for 6 months. 
The samples were analyzed for drug content by 
HPLC. The drug was degraded to a negligible 
extent and the degradation rate constant for 
optimized formulation was low (2.42 × 10−4). 
Because the overall degradation is <5%, a tentative 
shelf life of 2 years may be assigned to the 
optimized formulation. 
Conclusion 
Performed studies and obtained results prove the 
efficacy of chitosan/gellan gum based clindamycin 
in situ gel system for vaginal application. The 
formulation is non irritant, easy to administer along 
with good bioadhesive and retention properties. 
This formulation has potential for a better patient 
complaint vaginal formulation. The efficacy of the 
formulation can further be studied by in vivo and 
clinical experiments.  
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